ADMA Biologics ADMA Accumulated Depreciation
Accumulated Depreciation at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's accumulated depreciation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's accumulated depreciation?
- ADMA Biologics (ADMA) reported accumulated depreciation of $40M in Q1 2026.
- How has ADMA Biologics's accumulated depreciation changed year-over-year?
- ADMA Biologics's accumulated depreciation increased by 12.7% year-over-year, from $35.5M to $40M.
- What is the long-term trend for ADMA Biologics's accumulated depreciation?
- Over 5 years (2020 to 2025), ADMA Biologics's accumulated depreciation has grown at a 34.0% compound annual growth rate (CAGR), from $8.86M to $38.35M.
- What does accumulated depreciation mean?
- Total accumulated depreciation on property, plant, and equipment since acquisition — represents the consumed portion of asset useful lives.